CRSP Today - Jul 14: Market Reacts to New Stake

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

CRSP Today - Jul 14: Market Reacts to New Stake

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor, breaking down the day for CRISPR Therapeutics, ticker CRSP. Today was a bit of a bummer—it finished in the red, down about 1.3%. Not exactly what we wanted to see.

So, here’s the scoop. CRISPR started off okay, but then it kinda lost steam as the day went on. The volume was way lower than usual, so it felt like a slow day in the market. You know how sometimes stocks just seem to drift? Yeah, that was CRISPR today.

Now, what’s behind this move? Well, there’s been some buzz about Canal Insurance picking up a new stake in CRISPR. On the surface, that sounds good, right? But it didn’t really light a fire under the stock. It’s like people were saying, “Cool, but what else ya got?” There was also some chatter about other gene-editing stocks being highlighted as top picks for 2026, and CRISPR just didn’t seem to be the star of the show today. The market can be funny like that—sometimes good news just isn’t enough to get folks excited.

And here’s something to keep in mind: there’s been talk about a new “DNA shredder” technology that could change the game for gene-editing. It’s still early days, but if that really pans out, it could be a big deal for CRISPR. So, while today was a bit of a letdown, there’s potential on the horizon.

Alright, that’s a wrap for today! Just remember, I’m here to give you the lowdown on what’s happening, not to tell you what to do with your cash. Stay curious, keep learning, and catch you later!

まだレビューはありません